Defining the clinical clusters of severe asthma within UBIOPRED

Marijke Amelink (Amsterdam, Netherlands)

Source: International Congress 2015 – Fingerprinting severe asthma
Session: Fingerprinting severe asthma
Session type: Symposium
Number: 3456
Disease area: Airway diseases

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marijke Amelink (Amsterdam, Netherlands). Defining the clinical clusters of severe asthma within UBIOPRED. International Congress 2015 – Fingerprinting severe asthma

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Identifying asthma features in severe COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Improved definition of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019
Year: 2020



Defining acute asthma severity – how do worldwide asthma guidelines compare?
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018


Predicting frequent exacerbations in a severe asthma centre.
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020


Definition and impact of severe asthma
Source: Eur Respir Monogr 2019; 84: 1-15
Year: 2019


Clinical characteristics of severe asthma subphenotypes
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012

Clinical phenotypes of severe asthma: children
Source: Eur Respir Monogr 2019; 84: 64-81
Year: 2019


Assessing severe asthma
Source: Eur Respir J 2016; 48: 611-613
Year: 2016


Defining asthma phenotypes
Source: Annual Congress 2013 –MS4 Asthma phenotypes and endotypes
Year: 2013

The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007




Evolution from mild to severe asthma; the severe asthma clinic perspective
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


Genetic comparison between severe persistent asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 81s
Year: 2003

Are severe and moderate exacerbations different entities?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021


Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 72s
Year: 2007

Pathophysiology of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Defining asthma and COPD: differential diagnosis
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018